What is actually limiting us?

A useful service can be hard to finance; a profitable service can be of little use. The Inversion argues that this is a recurring feature of coordination through monetary return: what gets done depends heavily on who can pay and who can earn from doing it. The claim is strongest where a need is understood, people could meet it, and the work still has no viable funding route. Public services, insurance, charities and households already respond to needs outside a simple sale. The question is how well these arrangements close the gap, and where they leave it open.

Before explaining an unmet need, separate three situations. They can overlap, and a constraint today may have been avoidable years earlier.

1. The capacity is missing. A ward needs an experienced nurse tonight; nobody with the required skills is available. A larger budget cannot supply those years of training overnight.
2. The capacity is needed elsewhere. Moving that nurse from another ward may only move the danger. Allocation still requires a judgment about competing needs.
3. The capacity could meet the need, but the arrangement prevents it. A willing, qualified person cannot obtain a funded post, or useful preventive work has no purchaser who captures enough of its benefit.

Calling all three “a lack of money” hides different remedies. Training, better working conditions, a different allocation and a different funding rule solve different problems. Evidence for the third case requires tracing the actual people, skills, resources and decision—not just placing unemployment beside unmet need.

Prices can reveal scarcity while allocating access by purchasing power. Whether a signal is informative and whether its result is acceptable are separate questions.

The argument becomes useful when it risks being wrong. Look for:

• Unmet needs for which the apparent spare capacity disappears on inspection: the skills, equipment, location or safe working time do not match.
• Funding reforms that leave the bottleneck unchanged. If a post remains vacant after adequate funding and workable conditions are offered, finance alone was not the explanation.
• Institutions that reliably fund prevention or other benefits that nobody can readily sell. These show where existing arrangements already overcome the proposed mechanism.
• Comparable failures in alternative arrangements: idle capacity, concealed costs or arbitrary exclusion despite explicit commitments to meet needs.

One case cannot settle the prevalence of a mechanism. Repeated comparisons can narrow its scope—and test whether the proposed alternative improves anything.

Russia’s cuts in pipeline supply created a physical constraint in Europe. The IEA attributes the fall in EU gas demand to a combination of mild weather, efficiency, fuel switching, behavioural change and reduced industrial production. It would be too simple to say either that prices solved everything or that the shortage was only financial. Expensive gas encouraged substitution, but some demand disappeared because factories curtailed production. Governments also supported consumers. The remaining question is who bore the adjustment and which uses were protected.

Switzerland’s nursing initiative addresses both the supply of trained staff and the conditions that keep them in the profession. Its first-stage training measures entered into force on 1 July 2024. Obsan’s September 2026 forecast estimates that domestic training could cover 40–55% of the need for new nursing staff in 2024–2033, depending on the scenario; the training initiative could improve that coverage. The second-stage working-conditions bill was still with a Council of States committee in the parliamentary record checked on 8 November 2026. A proposal to improve conditions is not yet an improvement delivered.

How can shortages coexist with unemployment? SECO recorded 13,578 unemployed people whose last employer was in the broad health and social-work sector in October 2026. That is not a count of qualified nurses ready for the vacant shifts. Sector and occupation, headcount and working hours, unemployed people and all job seekers are different measures. Qualifications, language, location, health and workable schedules can prevent a match. Leaving an employer also need not mean leaving nursing: Obsan’s turnover measure counts the former. A nurse working in another profession is not unemployed, but may face barriers to returning. The totals alone cannot tell us who could fill which post.

Financing may still contribute to the shortage. Training needs supervised placements and time away from routine work; retaining staff may require better staffing and predictable shifts. But “the pipeline was sized to budget” is a hypothesis to investigate, not something the shortage itself proves. Trace where a training place, return to practice or funded post was refused, why it was refused, and whether the person could safely do the work. That reveals which bottleneck a different arrangement might actually remove.

Imagine someone who can remain at home with nursing visits, meals and help with everyday tasks. Swiss compulsory health insurance contributes to specified nursing services; patients contribute within statutory limits, and cantons or municipalities cover residual nursing costs. Home help, general support, board and accommodation usually fall to the person, with supplementary benefits or allowances available in some circumstances. A continuous need therefore crosses several funding rules. Whether support arrives can depend on which part qualifies, who coordinates it and what the household can afford.

Obsan’s 2025 status-quo scenario projects roughly 51% more long-term nursing-home beds for people aged 65 and over needed by 2040 than in 2023. This is a conditional projection, not a building target: health, care models and support at home affect the result. Funding fragmentation is one plausible source of gaps, alongside workforce limits and changing needs. A useful local investigation would follow a delayed discharge or an unsupported household across those boundaries, including relatives’ unpaid time. It should establish where help was unavailable and where available help could not be financed.

Effective antibiotics are used for a short course, and preserving their usefulness means avoiding unnecessary use. That creates a tension: a manufacturer recovering research costs through sales needs revenue, while good stewardship limits the volume sold. Achaogen’s plazomicin received US approval in June 2018; the company filed for Chapter 11 in April 2019. Approval alone did not make the business viable. The episode illustrates commercial risk after development, not proof that every failure is financial or that useful cures are deliberately suppressed.

WHO’s 2025 review finds the antibacterial pipeline insufficient. Discovering safe, effective drugs is scientifically difficult as well as commercially uncertain. The practical design question is whether paying for research or dependable availability, rather than rewarding volume alone, can sustain useful treatments while keeping them accessible. That is a narrower and more testable claim than saying medicine cannot profit from cures.

Bring a case with enough detail to distinguish explanations: the need, the available capability, the decision, the funding rule and what happened next. A case that turns out to be genuine scarcity is useful too. It prevents a general critique from becoming an answer supplied before the investigation begins.

The full Inversion develops the wider argument. Its discussion is a place to bring evidence that strengthens, limits or overturns it.